UST-29 version 24
Administrative fees, reimbursements of costs of expert activities, reimbursements of activities associated with the provision of information and reimbursements of other activities
This guideline supersedes guideline UST-29 version 23 with effect as of 1 June 2023.
Introduction
The guideline is being issued on the basis and in compliance with the provisions of Act No 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts, as amended (hereinafter referred to as the “Act on Pharmaceuticals“), of Act No 48/1997 Coll., on Public Health Insurance and on Amendments to Some Related Acts (hereinafter referred to as the “Act on Public Health Insurance”), of Act No 634/2004 Coll., on Administrative Fees, as amended (hereinafter referred to as the “Act on Administrative Fees“), of Act No 106/1999 Coll., on Free Access to Information, as amended (hereinafter referred to as the “Act on Free Access to Information“), of Act No 257/2001 Coll., on Libraries, as amended (hereinafter referred to as the “Act on Libraries”), of Act No 218/2000 Coll., on Budgetary Rules, as amended (hereinafter referred to as the “Act on Budgetary Rules“), of Act No 375/2022 Coll., on Medical Devices and In Vitro Diagnostic Medical Devices, as amended (hereinafter referred to as the “Act on Devices”), and Act No 167/1998 Coll., on Dependency-Producing Substances and on Amendments to Some Other Acts, as amended (hereinafter referred to as the “Act on Dependency-Producing Substances”).
The Guideline is for recommendation.
- UST-29_version24 (pdf, 303 kB)
- UST-29_version24_annex1 (pdf, 508 kB)
- UST-29_version24_annex2 (docx, 36 kB)
- UST-29_version24_annex3 (docx, 34 kB)
- UST-29_version24_annex4 (docx, 50 kB)
- UST-29_version24_annex5 (docx, 33 kB)